Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of a Therapeutic Mobile App for Depression

NCT: NCT05601362 · COMPLETED

NCT IDNCT05601362
StatusCOMPLETED
Start Date2023-03-30
Completion2023-08-30
SponsorChristopher G. Beevers (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is a preliminary evaluation of a gamified attention bias modification training (GAMBT) for reducing symptoms of depression and rumination. Individuals with elevated symptoms of depression will use the digital intervention over the course of 4 weeks. They will complete a brief (\~5 question) survey daily, as well as weekly assessments.

Frequently Asked Questions

What is Evaluation of a Therapeutic Mobile App for Depression?

Evaluation of a Therapeutic Mobile App for Depression is a clinical trial registered under NCT05601362. Current status: COMPLETED.

What is the status of NCT05601362?

The current status of NCT05601362 (Evaluation of a Therapeutic Mobile App for Depression) is: COMPLETED.

When did Evaluation of a Therapeutic Mobile App for Depression start?

Evaluation of a Therapeutic Mobile App for Depression started on 2023-03-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.